HKSE - Delayed Quote HKD
RemeGen Co., Ltd. (9995.HK)
39.200
+3.900
+(11.05%)
As of 2:55:09 PM GMT+8. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-1,501,829
-1,501,829
-1,263,689
263,631
-660,077
Investing Cash Flow
-817,650
-817,650
-841,557
-637,947
-479,065
Financing Cash Flow
978,307
978,307
2,426,949
-626,897
3,904,225
End Cash Position
726,552
726,552
2,069,180
1,756,821
2,768,521
Capital Expenditure
-852,739
-852,739
-757,517
-617,340
-480,834
Issuance of Capital Stock
-65,160
-65,160
2,571,538
-449,170
3,772,203
Issuance of Debt
1,125,840
1,125,840
--
--
683,192
Repayment of Debt
--
--
--
-108,000
-1,181,625
Free Cash Flow
-2,354,568
-2,354,568
-2,021,206
-353,709
-1,140,911
12/31/2020 - 11/9/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2171.HK CARsgen Therapeutics Holdings Limited
15.480
+3.34%
2696.HK Shanghai Henlius Biotech, Inc.
38.450
+1.99%
1952.HK Everest Medicines Limited
46.300
-6.84%
2157.HK Lepu Biopharma Co., Ltd.
4.320
+3.10%
9966.HK Alphamab Oncology
6.960
-4.92%
2142.HK HBM Holdings Limited
7.930
+1.02%
9606.HK Duality Biotherapeutics, Inc.
219.800
+0.55%
1530.HK 3SBIO
13.340
+4.22%
CSJ.MU CSL Ltd
134.06
+0.03%
CSJ.BE CSL Ltd
134.70
+0.24%